Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective

Biological Psychiatry

Volumn 81, Issue 10, 2017, Pages 874-885

  Krystal, John H ^a,b,d   Anticevic, Alan ^a,c   Yang, Genevieve J ^a   Dragoi, George ^a   Driesen, Naomi R ^a,d   Wang, Xiao Jing ^e   Murray, John D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c YALE UNIVERSITY   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^e NEW YORK UNIVERSITY   (United States)

Author keywords

Cognition; Computational psychiatry; Glutamate; Neural ensembles; Neurodevelopment; Schizophrenia

Indexed keywords

GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADAPTATION; CORTICAL EXCITABILITY; EXCITATION; HUMAN; NERVE CELL NETWORK; NEUROSCIENCE; NOISE; NONHUMAN; OSCILLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYNAPSE; WORKING MEMORY; ANIMAL; BRAIN CORTEX; COMPUTER SIMULATION; NERVE CELL; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CEREBRAL CORTEX; COMPUTER SIMULATION; HUMANS; NERVE NET; NEURONS; NEUROSCIENCES; SCHIZOPHRENIA;

EID: 85018623081     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2017.01.004     Document Type: Review

References (154)

1. 1 Somogyi, P., Tamas, G., Lujan, R., Buhl, E.H., Salient features of synaptic organisation in the cerebral cortex. Brain Res Rev 26 (1998), 113–135.
2. 2 Krystal, J.H., Anticevic, A., Murray, J.D., Glahn, D.C., Driesen, N., Yang, G., et al. Clinical heterogeneity arising from categorical and dimensional features of the neurobiology of psychiatric diagnoses: Insights from neuroimaging and computational neuroscience. Redish, A.D., Gordon, J.A., (eds.) Computational Psychiatry: New Perspectives on Mntal Illness, 2016, MIT Press, Cambridge, MA, 295–317.
3. 3 Staley, K., Molecular mechanisms of epilepsy. Nat Neurosci 18 (2015), 367–372.
4. 4 Uzunova, G., Pallanti, S., Hollander, E., Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics. World J Biol Psychiatry 17 (2016), 174–186.
5. 5 Krystal, J.H., Sanacora, G., Duman, R.S., Rapid-acting glutamatergic antidepressants: The path to ketamine and beyond. Biol Psychiatry 73 (2013), 1133–1141.
6. 6 Vita, A., De Peri, L., Deste, G., Sacchetti, E., Progressive loss of cortical gray matter in schizophrenia: A meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry, 2, 2012, e190.
7. 7 Kochunov, P., Hong, L.E., Neurodevelopmental and neurodegenerative models of schizophrenia: White matter at the center stage. Schizophr Bull 40 (2014), 721–728.
8. 8 Glahn, D.C., Ragland, J.D., Abramoff, A., Barrett, J., Laird, A.R., Bearden, C.E., et al. Beyond hypofrontality: A quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp 25 (2005), 60–69.
9. 9 Catts, V.S., Fung, S.J., Long, L.E., Joshi, D., Vercammen, A., Allen, K.M., et al. Rethinking schizophrenia in the context of normal neurodevelopment. Front Cell Neurosci, 7, 2013, 60.
10. 10 Need, A.C., McEvoy, J.P., Gennarelli, M., Heinzen, E.L., Ge, D., Maia, J.M., et al. Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. Am J Hum Genet 91 (2012), 303–312.
11. 11 Timms, A.E., Dorschner, M.O., Wechsler, J., Choi, K.Y., Kirkwood, R., Girirajan, S., et al. Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families. JAMA Psychiatry 70 (2013), 582–590.
12. 12 Li, Z., Chen, J., Xu, Y., Yi, Q., Ji, W., Wang, P., et al. Genome-wide analysis of the role of copy number variation in schizophrenia risk in Chinese. Biol Psychiatry 80 (2016), 331–337.
13. 13 Pocklington, A.J., Rees, E., Walters, J.T., Han, J., Kavanagh, D.H., Chambert, K.D., et al. Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia. Neuron, 86, 2015, 1203–1214.
14. 14 Sekar, A., Bialas, A.R., de Rivera, H., Davis, A., Hammond, T.R., Kamitaki, N., et al. Schizophrenia risk from complex variation of complement component 4. Nature 530 (2016), 177–183.
15. 15 (2014): Biological insights from 108 schizophrenia-associated genetic loci. Nature 511 (2014), 421–427.
16. 16 Pers, T.H., Timshel, P., Ripke, S., Lent, S., Sullivan, P.F., O'Donovan, M.C., et al. Comprehensive analysis of schizophrenia-associated loci highlights ion channel pathways and biologically plausible candidate causal genes. Hum Mol Genet 25 (2016), 1247–1254.
17. 17 Gulsuner, S., Walsh, T., Watts, A.C., Lee, M.K., Thornton, A.M., Casadei, S., et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 154 (2013), 518–529.
18. 18 Birnbaum, R., Jaffe, A.E., Chen, Q., Hyde, T.M., Kleinman, J.E., Weinberger, D.R., Investigation of the prenatal expression patterns of 108 schizophrenia-associated genetic loci. Biol Psychiatry 77 (2015), e43–e51.
19. 19 Hoftman, G.D., Datta, D., Lewis, D.A., Layer 3 excitatory and inhibitory circuitry in the prefrontal cortex: Developmental trajectories and alterations in schizophrenia [published online ahead of print Jun 4]. Biol Psychiatry, 2016.
20. 20 Wang, M., Yang, Y., Wang, C.J., Gamo, N.J., Jin, L.E., Mazer, J.A., et al. NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex. Neuron 77 (2013), 736–749.
21. 21 Wang, X.J., Synaptic basis of cortical persistent activity: The importance of NMDA receptors to working memory. J Neurosci 19 (1999), 9587–9603.
22. 22 Hoffman, R.E., Computer simulations of neural information processing and the schizophrenia–mania dichotomy. Arch Gen Psychiatry 44 (1987), 178–188.
23. 23 Hoffman, R.E., McGlashan, T.H., Parallel distributed processing and the emergence of schizophrenic symptoms. Schizophr Bull 19 (1993), 119–140.
24. 1H-MRS studies. Schizophr Bull 39 (2013), 120–129.
25. 25 de la Fuente-Sandoval, C., Reyes-Madrigal, F., Mao, X., Leon-Ortiz, P., Rodriguez-Mayoral, O., Solis-Vivanco, R., et al. Cortico-striatal GABAergic and glutamatergic dysregulations in subjects at ultra-high risk for psychosis investigated with proton magnetic resonance spectroscopy. Int J Neuropsychopharmacol, 19, 2016, pyv105.
26. 26 Yang, Z., Zhu, Y., Song, Z., Mei, L., Zhang, J., Chen, T., et al. Comparison of the density of gamma-aminobutyric acid in the ventromedial prefrontal cortex of patients with first-episode psychosis and healthy controls. Shanghai Arch Psychiatry 27 (2015), 341–347.
27. 27 Yoon, J.H., Maddock, R.J., Rokem, A., Silver, M.A., Minzenberg, M.J., Ragland, J.D., et al. GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J Neurosci 30 (2010), 3777–3781.
28. 1H-MRS study. Neuroimage Clin 6 (2014), 398–407.
29. 1H MRS study at 7 Tesla. Schizophr Res 172 (2016), 101–105.
30. 30 Rowland, L.M., Krause, B.W., Wijtenburg, S.A., McMahon, R.P., Chiappelli, J., Nugent, K.L., et al. Medial frontal GABA is lower in older schizophrenia: A MEGA-PRESS with macromolecule suppression study. Mol Psychiatry 21 (2016), 198–204.
31. 31 Anticevic, A., Corlett, P.R., Cole, M.W., Savic, A., Gancsos, M., Tang, Y., et al. N-Methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia. Biol Psychiatry 77 (2015), 569–580.
32. 32 Anticevic, A., Hu, X., Xiao, Y., Hu, J., Li, F., Bi, F., et al. Early-course unmedicated schizophrenia patients exhibit elevated prefrontal connectivity associated with longitudinal change. J Neurosci 35 (2015), 267–286.
33. 33 Schmidt, A., Smieskova, R., Aston, J., Simon, A., Allen, P., Fusar-Poli, P., et al. Brain connectivity abnormalities predating the onset of psychosis: Correlation with the effect of medication. JAMA Psychiatry 70 (2013), 903–912.
34. 34 Uhlhaas, P.J., Singer, W., Oscillations and neuronal dynamics in schizophrenia: The search for basic symptoms and translational opportunities. Biol Psychiatry 77 (2015), 1001–1009.
35. 35 Rivolta, D., Castellanos, N.P., Stawowsky, C., Helbling, S., Wibral, M., Grutzner, C., et al. Source-reconstruction of event-related fields reveals hyperfunction and hypofunction of cortical circuits in antipsychotic-naive, first-episode schizophrenia patients during Mooney face processing. J Neurosci 34 (2014), 5909–5917.
36. 36 Schobel, S.A., Chaudhury, N.H., Khan, U.A., Paniagua, B., Styner, M.A., Asllani, I., et al. Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron 78 (2013), 81–93.
37. 37 Moghaddam, B., Adams, B., Verma, A., Daly, D., Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17 (1997), 2921–2927.
38. 38 Krystal, J.H., Anticevic, A., Toward illness phase-specific pharmacotherapy for schizophrenia. Biol Psychiatry 78 (2015), 738–740.
39. 39 Turrigiano, G., Abbott, L.F., Marder, E., Activity-dependent changes in the intrinsic properties of cultured neurons. Science 264 (1994), 974–977.
40. 40 Tatavarty, V., Sun, Q., Turrigiano, G.G., How to scale down postsynaptic strength. J Neurosci 33 (2013), 13179–13189.
41. 41 Davis, G.W., Homeostatic control of neural activity: From phenomenology to molecular design. Annu Rev Neurosci 29 (2006), 307–323.
42. 42 Fauth, M., Tetzlaff, C., Opposing effects of neuronal activity on structural plasticity. Front Neuroanat, 10, 2016, 75.
43. 43 Rannals, M.D., Hamersky, G.R., Page, S.C., Campbell, M.N., Briley, A., Gallo, R.A., et al. Psychiatric risk gene transcription factor 4 regulates intrinsic excitability of prefrontal neurons via repression of SCN10a and KCNQ1. Neuron 90 (2016), 43–55.
44. 44 Forsingdal, A., Fejgin, K., Nielsen, V., Werge, T., Nielsen, J., 15q13.3 homozygous knockout mouse model display epilepsy-, autism- and schizophrenia-related phenotypes. Transl Psychiatry, 6, 2016, e860.
45. 45 Carr, G.V., Chen, J., Yang, F., Ren, M., Yuan, P., Tian, Q., et al. KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophrenia. Mol Psychiatry 21 (2016), 1517–1526.
46. 46 Bigos, K.L., Mattay, V.S., Callicott, J.H., Straub, R.E., Vakkalanka, R., Kolachana, B., et al. Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch Gen Psychiatry 67 (2010), 939–945.
47. 47 Tatard-Leitman, V.M., Jutzeler, C.R., Suh, J., Saunders, J.A., Billingslea, E.N., Morita, S., et al. Pyramidal cell selective ablation of N- methyl-D-aspartate receptor 1 causes increase in cellular and network excitability. Biol Psychiatry 77 (2015), 556–568.
48. 48 Carlen, M., Meletis, K., Siegle, J.H., Cardin, J.A., Futai, K., Vierling-Claassen, D., et al. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry 17 (2012), 537–548.
49. 49 Lewis, D.A., Gonzalez-Burgos, G., Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 33 (2008), 141–165.
50. 50 Inan, M., Anderson, S.A., The chandelier cell, form and function. Curr Opin Neurobiol 26 (2014), 142–148.
51. 51 Klausberger, T., Marton, L.F., O'Neill, J., Huck, J.H., Dalezios, Y., Fuentealba, P., et al. Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J Neurosci 25 (2005), 9782–9793.
52. 52 Lin, L.C., Sibille, E., Somatostatin, neuronal vulnerability and behavioral emotionality. Mol Psychiatry 20 (2015), 377–387.
53. 53 Chung, D.W., Fish, K.N., Lewis, D.A., Pathological basis for deficient excitatory drive to cortical parvalbumin interneurons in schizophrenia. Am J Psychiatry 173 (2016), 1131–1139.
54. 54 Georgiev, D., Arion, D., Enwright, J.F., Kikuchi, M., Minabe, Y., Corradi, J.P., et al. Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia. Am J Psychiatry 171 (2014), 62–71.
55. 55 Hoftman, G.D., Volk, D.W., Bazmi, H.H., Li, S., Sampson, A.R., Lewis, D.A., Altered cortical expression of GABA-related genes in schizophrenia: Illness progression vs. developmental disturbance. Schizophr Bull 41 (2015), 180–191.
56. 56 Homayoun, H., Moghaddam, B., NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27 (2007), 11496–11500.
57. 57 Moghaddam, B., Adams, B., Verma, A., Daly, D., Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17 (1997), 2921–2927.
58. 1H-MRS: Relationship to ketamine-induced psychopathology. Mol Psychiatry 17 (2012), 664–665.
59. 59 Pinault, D., N-Methyl D-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biol Psychiatry 63 (2008), 730–735.
60. 60 Hong, L.E., Summerfelt, A., Buchanan, R.W., O'Donnell, P., Thaker, G.K., Weiler, M.A., et al. Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology 35 (2010), 632–640.
61. 61 Billingslea, E.N., Tatard-Leitman, V.M., Anguiano, J., Jutzeler, C.R., Suh, J., Saunders, J.A., et al. Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits. Neuropsychopharmacology 39 (2014), 1603–1613.
62. 62 McGinley, M.J., David, S.V., McCormick, D.A., Cortical membrane potential signature of optimal states for sensory signal detection. Neuron 87 (2015), 179–192.
63. 63 Van Snellenberg, J.X., Girgis, R.R., Horga, G., van de Giessen, E., Slifstein, M., Ojeil, N., et al. Mechanisms of working memory impairment in schizophrenia. Biol Psychiatry 80 (2016), 617–626.
64. 64 Arnsten, A.F., Wang, M., Paspalas, C.D., Dopamine's actions in primate prefrontal cortex: Challenges for treating cognitive disorders. Pharmacol Rev 67 (2015), 681–696.
65. 65 Mair, R.G., Hembrook, J.R., Memory enhancement with event-related stimulation of the rostral intralaminar thalamic nuclei. J Neurosci 28 (2008), 14293–14300.
66. 66 Grossberg, S., Some normal and abnormal behavioral syndromes due to transmitter gating of opponent processes. Biol Psychiatry 19 (1984), 1075–1118.
67. 67 Grossberg, S., The imbalanced brain: From normal behavior to schizophrenia. Biol Psychiatry 48 (2000), 81–98.
68. 68 Driesen, N.R., Leung, H.C., Calhoun, V.D., Constable, R.T., Gueorguieva, R., Hoffman, R., et al. Impairment of working memory maintenance and response in schizophrenia: Functional magnetic resonance imaging evidence. Biol Psychiatry 64 (2008), 1026–1034.
69. 69 Driesen, N.R., McCarthy, G., Bhagwagar, Z., Bloch, M., Calhoun, V., D'Souza, D.C., et al. Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Mol Psychiatry 18 (2013), 1199–1204.
70. 70 Driesen, N.R., McCarthy, G., Bhagwagar, Z., Bloch, M.H., Calhoun, V.D., D'Souza, D.C., et al. The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity. Neuropsychopharmacology 38 (2013), 2613–2622.
71. 71 Francis, A., Msall, M., Obringer, E., Kelley, K., Children with autism spectrum disorder and epilepsy. Pediatr Ann 42 (2013), 255–260.
72. 72 Brunel, N., Wang, X.J., Effects of neuromodulation in a cortical network model of object working memory dominated by recurrent inhibition. J Comput Neurosci 11 (2001), 63–85.
73. 73 Durstewitz, D., Seamans, J.K., Sejnowski, T.J., Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. J Neurophysiol 83 (2000), 1733–1750.
74. 74 Arnsten, A.F., Girgis, R.R., Gray, D.L., Mailman, R.B., Novel dopamine therapeutics for cognitive deficits in schizophrenia. Biol Psychiatry 81 (2017), 67–77.
75. 75 Slifstein, M., van de Giessen, E., Van Snellenberg, J., Thompson, J.L., Narendran, R., Gil, R., et al. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: A positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry 72 (2015), 316–324.
76. 76 Arnsten, A.F., Jin, L.E., Molecular influences on working memory circuits in dorsolateral prefrontal cortex. Prog Mol Biol Transl Sci 122 (2014), 211–231.
77. 77 Krystal, J.H., Perry, E.B. Jr., Gueorguieva, R., Belger, A., Madonick, S.H., Abi-Dargham, A., et al. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: Implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62 (2005), 985–994.
78. 78 Dursun, S.M., Deakin, J.F., Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: A naturalistic case-series outcome study. J Psychopharmacol 15 (2001), 297–301.
79. 79 Tiihonen, J., Hallikainen, T., Ryynänen, O.-P., Repo-Tiihonen, E., Kotilainen, I., Eronen, M., et al. Lamotrigine in treatment-resistant schizophrenia: A randomized placebo-controlled crossover trial. Biol Psychiatry 54 (2003), 1–6.
80. 2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial. Nat Med 13 (2007), 1102–1107.
81. 81 Hoffman, R.E., Hampson, M., Wu, K., Anderson, A.W., Gore, J.C., Buchanan, R.J., et al. Probing the pathophysiology of auditory/verbal hallucinations by combining functional magnetic resonance imaging and transcranial magnetic stimulation. Cereb Cortex 17 (2007), 2733–2743.
82. 82 Goff, D.C., Keefe, R., Citrome, L., Davy, K., Krystal, J.H., Large, C., et al. Lamotrigine as add-on therapy in schizophrenia: Results of 2 placebo-controlled trials. J Clin Psychopharmacol 27 (2007), 582–589.
83. 83 Stauffer, V.L., Millen, B.A., Andersen, S., Kinon, B.J., Lagrandeur, L., Lindenmayer, J.P., et al. Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo. Schizophr Res 150 (2013), 434–441.
84. 84 Adams, D.H., Zhang, L., Millen, B.A., Kinon, B.J., Gomez, J.C., Pomaglumetad methionil (LY2140023 monohydrate) and aripiprazole in patients with schizophrenia: A phase 3, multicenter, double-blind comparison. Schizophr Res Treat, 2014, 2014, 758212.
85. 85 Downing, A.M., Kinon, B.J., Millen, B.A., Zhang, L., Liu, L., Morozova, M.A., et al. A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia. BMC Psychiatry, 14, 2014, 351.
86. 86 Kinon, B.J., Millen, B.A., Zhang, L., McKinzie, D.L., Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophrenia. Biol Psychiatry 78 (2015), 754–762.
87. 87 Rao, S.G., Williams, G.V., Goldman-Rakic, P.S., Isodirectional tuning of adjacent interneurons and pyramidal cells during working memory: Evidence for microcolumnar organization in PFC. J Neurophysiol 81 (1999), 1903–1916.
88. 88 Rao, S.G., Williams, G.V., Goldman-Rakic, P.S., Destruction and creation of spatial tuning by disinhibition: GABA-A blockade of prefrontal cortical neurons engaged by working memory. J Neurosci 20 (2000), 485–494.
89. 89 Spanne, A., Jorntell, H., Questioning the role of sparse coding in the brain. Trends Neurosci 38 (2015), 417–427.
90. 90 Buzsaki, G., Watson, B.O., Brain rhythms and neural syntax: Implications for efficient coding of cognitive content and neuropsychiatric disease. Dialogues Clin Neurosci, 14, 2012, 345–367.
91. 91 Wang, X.J., Tegner, J., Constantinidis, C., Goldman-Rakic, P.S., Division of labor among distinct subtypes of inhibitory neurons in a cortical microcircuit of working memory. Proc Natl Acad Sci U S A 101 (2004), 1368–1373.
92. 92 Yang, G.R., Murray, J.D., Wang, X.J., A dendritic disinhibitory circuit mechanism for pathway-specific gating. Nat Commun, 7, 2016, 12815.
93. 93 Lee, A.T., Gee, S.M., Vogt, D., Patel, T., Rubenstein, J.L., Sohal, V.S., Pyramidal neurons in prefrontal cortex receive subtype-specific forms of excitation and inhibition. Neuron 81 (2014), 61–68.
94. 94 Stefanelli, T., Bertollini, C., Luscher, C., Muller, D., Mendez, P., Hippocampal somatostatin interneurons control the size of neuronal memory ensembles. Neuron 89 (2016), 1074–1085.
95. 95 Murray, J.D., Anticevic, A., Gancsos, M., Ichinose, M., Corlett, P.R., Krystal, J.H., et al. Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model. Cereb Cortex 24 (2014), 859–872.
96. 96 Lin, A.C., Bygrave, A.M., de Calignon, A., Lee, T., Miesenbock, G., Sparse, decorrelated odor coding in the mushroom body enhances learned odor discrimination. Nat Neurosci 17 (2014), 559–568.
97. 97 Buzsaki, G., Neural syntax: Cell assemblies, synapsembles, and readers. Neuron 68 (2010), 362–385.
98. 98 Sturgill, J.F., Isaacson, J.S., Somatostatin cells regulate sensory response fidelity via subtractive inhibition in olfactory cortex. Nat Neurosci 18 (2015), 531–535.
99. 99 Anand, A., Charney, D.S., Oren, D.A., Berman, R.M., Hu, X.S., Cappiello, A., et al. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry 57 (2000), 270–276.
100. 100 Schmack, K., Gomez-Carrillo de Castro, A., Rothkirch, M., Sekutowicz, M., Rossler, H., Haynes, J.D., et al. Delusions and the role of beliefs in perceptual inference. J Neurosci 33 (2013), 13701–13712.
101. 101 Adams, R.A., Stephan, K.E., Brown, H.R., Frith, C.D., Friston, K.J., The computational anatomy of psychosis. Front Psychiatry, 4, 2013, 47.
102. 102 Yang, G.J., Murray, J.D., Wang, X.J., Glahn, D.C., Pearlson, G.D., Repovs, G., et al. Functional hierarchy underlies preferential connectivity disturbances in schizophrenia. Proc Natl Acad Sci U S A 113 (2016), E219–E228.
103. 103 Callicott, J.H., Bertolino, A., Mattay, V.S., Langheim, F.J., Duyn, J., Coppola, R., et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 10 (2000), 1078–1092.
104. 104 Starc, M., Murray, J.D., Santamauro, N., Savic, A., Diehl, C., Cho, Y.T., et al. Schizophrenia is associated with a pattern of spatial working memory deficits consistent with cortical disinhibition. Schizophr Res 181 (2017), 107–116.
105. 105 Deserno, L., Sterzer, P., Wustenberg, T., Heinz, A., Schlagenhauf, F., Reduced prefrontal–parietal effective connectivity and working memory deficits in schizophrenia. J Neurosci 32 (2012), 12–20.
106. 106 Javitt, D.C., Strous, R.D., Grochowski, S., Ritter, W., Cowan, N., Impaired precision, but normal retention, of auditory sensory (“echoic”) memory information in schizophrenia. J Abnorm Psychol 106 (1997), 315–324.
107. 107 March, L., Cienfuegos, A., Goldbloom, L., Ritter, W., Cowan, N., Javitt, D.C., Normal time course of auditory recognition in schizophrenia, despite impaired precision of the auditory sensory (“echoic”) memory code. J Abnorm Psychol, 108, 1999, 69–75.
108. 108 Gold, J.M., Hahn, B., Zhang, W.W., Robinson, B.M., Kappenman, E.S., Beck, V.M., et al. Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia. Arch Gen Psychiatry 67 (2010), 570–577.
109. 109 Corlett, P.R., Taylor, J.R., Wang, X.J., Fletcher, P.C., Krystal, J.H., Toward a neurobiology of delusions. Prog Neurobiol 92 (2010), 345–369.
110. 110 Corlett, P.R., Simons, J.S., Pigott, J.S., Gardner, J.M., Murray, G.K., Krystal, J.H., et al. Illusions and delusions: Relating experimentally-induced false memories to anomalous experiences and ideas. Front Behav Neurosci, 3, 2009, 53.
111. 111 Javitt, D.C., Freedman, R., Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. Am J Psychiatry 172 (2015), 17–31.
112. 112 Krystal, J.H., Abi-Saab, W., Perry, E., D'Souza, D.C., Liu, N., Gueorguieva, R., et al. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl) 179 (2005), 303–309.
113. 113 Hebb, D.O., The Organization of Behavior. 1949, John Wiley, New York.
114. 114 Funahashi, S., Chafee, M.V., Goldman-Rakic, P.S., Prefrontal neuronal activity in rhesus monkeys performing a delayed anti-saccade task. Nature 365 (1993), 753–756.
115. 115 Sohal, V.S., Zhang, F., Yizhar, O., Deisseroth, K., Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459 (2009), 698–702.
116. 116 Spencer, K.M., Nestor, P.G., Niznikiewicz, M.A., Salisbury, D.F., Shenton, M.E., McCarley, R.W., Abnormal neural synchrony in schizophrenia. J Neurosci 23 (2003), 7407–7411.
117. 117 Pratt, J., Dawson, N., Morris, B.J., Grent-’t-Jong, T., Roux, F., Uhlhaas, P.J., Thalamo-cortical communication, glutamatergic neurotransmission and neural oscillations: A unique window into the origins of ScZ?. Schizophr Res 180 (2017), 4–12.
118. 118 Hirano, Y., Oribe, N., Kanba, S., Onitsuka, T., Nestor, P.G., Spencer, K.M., Spontaneous gamma activity in schizophrenia. JAMA Psychiatry 72 (2015), 813–821.
119. 119 Rivolta, D., Heidegger, T., Scheller, B., Sauer, A., Schaum, M., Birkner, K., et al. Ketamine dysregulates the amplitude and connectivity of high-frequency oscillations in cortical–subcortical networks in humans: Evidence from resting-state magnetoencephalography-recordings. Schizophr Bull 41 (2015), 1105–1114.
120. 120 Rotaru, D.C., Yoshino, H., Lewis, D.A., Ermentrout, G.B., Gonzalez-Burgos, G., Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: Relevance for schizophrenia. J Neurosci 31 (2011), 142–156.
121. 121 Wang, H.X., Gao, W.J., Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex. Neuropsychopharmacology 34 (2009), 2028–2040.
122. 122 Lu, J.T., Li, C.Y., Zhao, J.P., Poo, M.M., Zhang, X.H., Spike-timing-dependent plasticity of neocortical excitatory synapses on inhibitory interneurons depends on target cell type. J Neurosci 27 (2007), 9711–9720.
123. 123 Urban-Ciecko, J., Barth, A.L., Somatostatin-expressing neurons in cortical networks. Nat Rev Neurosci 17 (2016), 401–409.
124. 124 Pfeffer, C.K., Xue, M., He, M., Huang, Z.J., Scanziani, M., Inhibition of inhibition in visual cortex: The logic of connections between molecularly distinct interneurons. Nat Neurosci 16 (2013), 1068–1076.
125. 125 Scheyltjens, I., Arckens, L., The current status of somatostatin-interneurons in inhibitory control of brain function and plasticity. Neural Plast, 2016, 2016, 8723623.
126. 126 Chiu, C.Q., Lur, G., Morse, T.M., Carnevale, N.T., Ellis-Davies, G.C., Higley, M.J., Compartmentalization of GABAergic inhibition by dendritic spines. Science 340 (2013), 759–762.
127. 127 Stokes, C.C., Teeter, C.M., Isaacson, J.S., Single dendrite-targeting interneurons generate branch-specific inhibition. Front Neural Circuits, 8, 2014, 139.
128. 128 Lisman, J.E., Jensen, O., The theta-gamma neural code. Neuron 77 (2013), 1002–1016.
129. 129 Alekseichuk, I., Turi, Z., Amador de Lara, G., Antal, A., Paulus, W., Spatial working memory in humans depends on theta and high gamma synchronization in the prefrontal cortex. Curr Biol 26 (2016), 1513–1521.
130. 130 Lega, B., Burke, J., Jacobs, J., Kahana, M.J., Slow-theta-to-gamma phase-amplitude coupling in human hippocampus supports the formation of new episodic memories. Cereb Cortex 26 (2016), 268–278.
131. 131 O'Keefe, J., Recce, M.L., Phase relationship between hippocampal place units and the EEG theta rhythm. Hippocampus 3 (1993), 317–330.
132. 132 Ekstrom, A.D., Meltzer, J., McNaughton, B.L., Barnes, C.A., NMDA receptor antagonism blocks experience-dependent expansion of hippocampal “place fields”. Neuron 31 (2001), 631–638.
133. 133 Dragoi, G., Tonegawa, S., Development of schemas revealed by prior experience and NMDA receptor knock-out. eLife, 2, 2013, e01326.
134. 134 Sun, L., Castellanos, N., Grutzner, C., Koethe, D., Rivolta, D., Wibral, M., et al. Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naive, first episode schizophrenia. Schizophr Res 150 (2013), 519–525.
135. 135 Kirihara, K., Rissling, A.J., Swerdlow, N.R., Braff, D.L., Light, G.A., Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia. Biol Psychiatry 71 (2012), 873–880.
136. 136 Koutsoukos, E., Angelopoulos, E., Maillis, A., Papadimitriou, G.N., Stefanis, C., Indication of increased phase coupling between theta and gamma EEG rhythms associated with the experience of auditory verbal hallucinations. Neurosci Lett 534 (2013), 242–245.
137. 137 Katona, I., Sperlagh, B., Magloczky, Z., Santha, E., Kofalvi, A., Czirjak, S., et al. GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience 100 (2000), 797–804.
138. 138 Robbe, D., Buzsaki, G., Alteration of theta timescale dynamics of hippocampal place cells by a cannabinoid is associated with memory impairment. J Neurosci 29 (2009), 12597–12605.
139. 139 Robbe, D., Montgomery, S.M., Thome, A., Rueda-Orozco, P.E., McNaughton, B.L., Buzsaki, G., Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci 9 (2006), 1526–1533.
140. 140 Carter, E., Wang, X.J., Cannabinoid-mediated disinhibition and working memory: Dynamical interplay of multiple feedback mechanisms in a continuous attractor model of prefrontal cortex. Cereb Cortex 17:Suppl 1 (2007), i16–i26.
141. 141 Dragoi, G., Buzsáki, G., Temporal encoding of place sequences by hippocampal cell assemblies. Neuron 50 (2006), 145–157.
142. 142 Anticevic, A., Gancsos, M., Murray, J.D., Repovs, G., Driesen, N.R., Ennis, D.J., et al. NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proc Natl Acad Sci U S A 109 (2012), 16720–16725.
143. 143 Whitfield-Gabrieli, S., Thermenos, H.W., Milanovic, S., Tsuang, M.T., Faraone, S.V., McCarley, R.W., et al. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A 106 (2009), 1279–1284.
144. 144 Lynall, M.E., Bassett, D.S., Kerwin, R., McKenna, P.J., Kitzbichler, M., Muller, U., et al. Functional connectivity and brain networks in schizophrenia. J Neurosci 30 (2010), 9477–9487.
145. 145 Lo, C.Y., Su, T.W., Huang, C.C., Hung, C.C., Chen, W.L., Lan, T.H., et al. Randomization and resilience of brain functional networks as systems-level endophenotypes of schizophrenia. Proc Natl Acad Sci U S A 112 (2015), 9123–9128.
146. 146 Yang, G.J., Murray, J.D., Repovs, G., Cole, M.W., Savic, A., Glasser, M.F., et al. Altered global brain signal in schizophrenia. Proc Natl Acad Sci U S A 111 (2014), 7438–7443.
147. 147 Hamm, J.P., Gilmore, C.S., Clementz, B.A., Augmented gamma band auditory steady-state responses: Support for NMDA hypofunction in schizophrenia. Schizophr Res 138 (2012), 1–7.
148. 148 Molina, V., Bachiller, A., Suazo, V., Lubeiro, A., Poza, J., Hornero, R., Noise power associated with decreased task-induced variability of brain electrical activity in schizophrenia. Eur Arch Psychiatry Clin Neurosci 266 (2016), 55–61.
149. 149 Feinberg, I., Guazzelli, M., Schizophrenia—a disorder of the corollary discharge systems that integrate the motor systems of thought with the sensory systems of consciousness. Br J Psychiatry 174 (1999), 196–204.
150. 150 Hiatt, J.F., Floyd, T.C., Katz, P.H., Feinberg, I., Further evidence of abnormal non-rapid-eye-movement sleep in schizophrenia. Arch Gen Psychiatry 42 (1985), 797–802.
151. 151 Ferrarelli, F., Huber, R., Peterson, M.J., Massimini, M., Murphy, M., Riedner, B.A., et al. Reduced sleep spindle activity in schizophrenia patients. Am J Psychiatry 164 (2007), 483–492.
152. 152 Olcese, U., Esser, S.K., Tononi, G., Sleep and synaptic renormalization: A computational study. J Neurophysiol 104 (2010), 3476–3493.
153. 153 Vyazovskiy, V.V., Cirelli, C., Pfister-Genskow, M., Faraguna, U., Tononi, G., Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. Nat Neurosci 11 (2008), 200–208.
154. 154 Manoach, D.S., Cain, M.S., Vangel, M.G., Khurana, A., Goff, D.C., Stickgold, R., A failure of sleep-dependent procedural learning in chronic, medicated schizophrenia. Biol Psychiatry 56 (2004), 951–956.